John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Viridian Therapeutics
VRDN
$2.74B
| $3M | 0.01% |
222,399
-202,138
| -48% | -$3.44M |
|
1402
NiSource
NI
$19.5B
| $2.99M | 0.01% |
74,705
-23,895
| -24% | -$920K |
|
1403
Metropolitan Bank Holding Corp
MCB
$1.13B
| $2.98M | 0.01% |
53,292
+16,753
| +46% | +$995K |
|
1404
Dime Commercial Bancshares
DCOM
$1.78B
| $2.98M | 0.01% |
106,965
+43,404
| +68% | +$1.31M |
|
1405
XPO
XPO
$22.5B
| $2.98M | 0.01% |
27,703
+3
| +0% | +$381 |
|
|
LOVE
1406
LoveSac
LOVE
$233M
| $2.98M | 0.01% |
163,784
+77,144
| +89% | +$1.69M |
|
1407
Bumble
BMBL
$375M
| $2.98M | 0.01% |
685,870
+627,354
| +1,072% | +$4.09M |
|
1408
Rapid7
RPD
$818M
| $2.98M | 0.01% |
112,276
-29,891
| -21% | -$1.02M |
|
1409
Pentair
PNR
$9.97B
| $2.96M | 0.01% |
33,824
-2,114
| -6% | -$201K |
|
1410
Coty
COTY
$2.35B
| $2.96M | 0.01% |
540,325
-287,578
| -35% | -$1.8M |
|
1411
Vishay Intertechnology
VSH
$4.8B
| $2.95M | 0.01% |
185,659
+33,699
| +22% | +$577K |
|
1412
W&T Offshore
WTI
$543M
| $2.95M | 0.01% |
1,901,705
-95,292
| -5% | -$157K |
|
|
ODP
1413
DELISTED
ODP
ODP
| $2.95M | 0.01% |
205,637
+178,373
| +654% | +$3.42M |
|
1414
Tronox
TROX
$880M
| $2.94M | 0.01% |
418,162
-94,577
| -18% | -$814K |
|
1415
Walt Disney
DIS
$192B
| $2.94M | 0.01% |
29,800
-48,787
| -62% | -$5.24M |
|
1416
Pacira BioSciences
PCRX
$1.02B
| $2.94M | 0.01% |
118,344
+3,662
| +3% | +$87.7K |
|
|
PSTL
1417
Postal Realty Trust
PSTL
$708M
| $2.94M | 0.01% |
205,873
+81,638
| +66% | +$1.1M |
|
1418
TE Connectivity
TEL
$58.3B
| $2.94M | 0.01% |
20,771
-2,890
| -12% | -$428K |
|
1419
Nucor
NUE
$56.2B
| $2.93M | 0.01% |
24,381
-153,097
| -86% | -$19.7M |
|
1420
BellRing Brands
BRBR
$1.25B
| $2.93M | 0.01% |
39,400
-8,633
| -18% | -$634K |
|
1421
Dillards
DDS
$9.95B
| $2.93M | 0.01% |
8,179
+2,532
| +45% | +$1.09M |
|
1422
State Street SPDR S&P 500 ESG ETF
EFIV
$1.03B
| $2.93M | 0.01% |
54,700
-139,200
| -72% | -$7.82M |
|
1423
Ascendis Pharma A/S
ASND
$16.6B
| $2.92M | 0.01% |
18,761
+7,846
| +72% | +$1.12M |
|
1424
EverQuote
EVER
$946M
| $2.92M | 0.01% |
111,616
-66,227
| -37% | -$1.52M |
|
1425
Medifast
MED
$136M
| $2.92M | 0.01% |
216,723
-15,346
| -7% | -$230K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.